| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 351,2 M € | +10.6% | 317,5 M € | +13.9% | 278,7 M € | +23.2% | 226,1 M € | +31.3% | 172,2 M € | +6.5% | 161,7 M € | +17.2% | 138,0 M € | +18.0% | 116,9 M € | -25.0% | 155,9 M € | -8.0% | 169,5 M € | -3.1% | 174,9 M € | -10.0% | 194,4 M € | -2.8% | 199,9 M € | -12.0% | 227,3 M € | -8.0% | 247,2 M € | -0.8% | 249,1 M € | -49.8% | 496,3 M € | +7.5% | 461,8 M € | +2.1% | 452,5 M € | |
| EBITDA | 12,1 M € | +36.9% | 8,9 M € | -15.1% | 10,4 M € | +38.5% | 7,5 M € | +37.4% | 5,5 M € | +17.3% | 4,7 M € | -11.9% | 5,3 M € | -9.8% | 5,9 M € | +42.2% | 4,1 M € | -27.0% | 5,7 M € | +84.3% | 3,1 M € | -67.2% | 9,4 M € | -4.9% | 9,9 M € | -22.1% | 12,6 M € | -38.2% | 20,4 M € | -6.5% | 21,9 M € | -30.6% | 31,5 M € | +53.2% | 20,6 M € | -19.6% | 25,6 M € | |
| Operating profit | 12,0 M € | +35.6% | 8,8 M € | -14.1% | 10,3 M € | +37.6% | 7,5 M € | +27.9% | 5,8 M € | +29.3% | 4,5 M € | -12.1% | 5,1 M € | -10.8% | 5,8 M € | +54.2% | 3,7 M € | -31.0% | 5,4 M € | +103.8% | 2,7 M € | -70.2% | 8,9 M € | -5.3% | 9,4 M € | -22.3% | 12,1 M € | -40.0% | 20,2 M € | -6.1% | 21,5 M € | -28.9% | 30,2 M € | +58.1% | 19,1 M € | -22.5% | 24,7 M € | |
| Profit/loss | 8,6 M € | +5.6% | 8,2 M € | -10.1% | 9,1 M € | +75.0% | 5,2 M € | +33.8% | 3,9 M € | +29.9% | 3,0 M € | -2.6% | 3,1 M € | -19.4% | 3,8 M € | +90.9% | 2,0 M € | -36.5% | 3,1 M € | +78.7% | 1,8 M € | -73.7% | 6,7 M € | +249.7% | -4,5 M € | -184.4% | 5,3 M € | +171.1% | 1,9 M € | -89.8% | 19,0 M € | +12.4% | 16,9 M € | +494.7% | 2,8 M € | -81.7% | 15,6 M € | |
| Equity | 46,9 M € | +22.6% | 38,2 M € | -39.4% | 63,0 M € | +16.9% | 53,9 M € | +10.7% | 48,7 M € | +8.7% | 44,8 M € | +7.2% | 41,8 M € | +7.9% | 38,8 M € | +10.9% | 35,0 M € | +6.1% | 33,0 M € | -2.5% | 33,8 M € | +5.5% | 32,1 M € | +26.3% | 25,4 M € | -27.2% | 34,8 M € | +10.4% | 31,6 M € | -35.1% | 48,6 M € | +4.3% | 46,6 M € | -17.8% | 56,7 M € | +5.3% | 53,8 M € | |
| Total assets | 105,4 M € | +19.7% | 88,0 M € | -6.5% | 94,1 M € | -5.5% | 99,6 M € | +10.0% | 90,6 M € | +24.3% | 72,8 M € | +16.7% | 62,4 M € | -0.6% | 62,8 M € | -2.3% | 64,3 M € | +1.8% | 63,1 M € | +2.1% | 61,8 M € | -2.5% | 63,4 M € | -5.4% | 67,0 M € | -20.6% | 84,4 M € | -30.3% | 121,1 M € | +19.8% | 101,1 M € | -15.7% | 120,0 M € | -26.5% | 163,2 M € | +36.9% | 119,2 M € | |
| Cash | 1,5 M € | +96.1% | 752,5 k € | -26.2% | 1,0 M € | -19.0% | 1,3 M € | +9.8% | 1,1 M € | +16.8% | 981,6 k € | -2.5% | 1,0 M € | -74.2% | 3,9 M € | +696.4% | 489,1 k € | +7.7% | 454,2 k € | +41.3% | 321,5 k € | -34.4% | 490,1 k € | -26.4% | 665,5 k € | +56.3% | 425,9 k € | -70.0% | 1,4 M € | -83.9% | 8,8 M € | -30.0% | 12,6 M € | +17.8% | 10,7 M € | +402.0% | 2,1 M € | |
| Debts | 58,5 M € | +17.4% | 49,8 M € | +60.3% | 31,1 M € | -25.1% | 41,5 M € | -0.6% | 41,8 M € | +52.1% | 27,5 M € | +36.5% | 20,1 M € | -9.4% | 22,2 M € | -19.5% | 27,6 M € | -3.3% | 28,5 M € | +13.3% | 25,2 M € | -8.2% | 27,4 M € | -5.6% | 29,0 M € | -12.4% | 33,2 M € | -11.5% | 37,5 M € | -18.7% | 46,1 M € | -11.0% | 51,8 M € | -41.5% | 88,5 M € | +39.9% | 63,3 M € | |
| Staff | 234,4 | 221,7 | 211,5 | 187,2 | 179,6 | 171 | 163,3 | 166,9 | 174,5 | 178,1 | 192,3 | 193,3 | 225,9 | 330,2 | 491,2 | 485,2 | 570,5 | 556,3 | 577,3 | |||||||||||||||||||
Public limited company · Dilbeek · incorporated on 28/11/1948 · 234,4 ETP
Public limited company profitable and well capitalised. Cash position rising (+96.1%).
Solid counterparty for a standard engagement.
AstraZeneca is a Public limited company incorporated in 1948. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Dilbeek. It employs on average 234,4 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette